Latest / JACC Specialty Journals
Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy | JACC: CardioOncology
Dr. Qun Shao discusses two multicenter studies evaluating cardiovascular adverse events associated with bispecific T‑cell engager therapies. Drawing on data from over 700 patients, the episode highlights the incidence, predictors, and clinical impact of cardiovascular complications, emphasizing the importance of baseline risk assessment, targeted monitoring, and multidisciplinary management as use of these therapies continues to expand.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.